Home/ Supplements/ Vitamin K/ IVC-Max Formula

IVC-Max Formula

product on market Capsule Allergy Research Group Safety: 96/100
96/100

This product looks safe

  • Niacinamide: 100mg is 2.9× the Tolerable Upper Intake Level (35mg)
  • 67% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

This formula contains Vitamin C and Niacinamide, which have strong evidence for supporting immune function and metabolic processes. Biotin and Vitamin K1 provide moderate support for cellular health and blood coagulation. Overall evidence coverage for this specific ingredient profile is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacinamide: 100mg is 2.9× the Tolerable Upper Intake Level (35mg)

Label

Product Label

Label for IVC-Max Formula
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
45
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
10 {Calories}
2.5 mg (3125% DV)
20.8× RDA — above typical dose 275 studies (A:9, B:175)
200 mcg (66% DV)
6.7× RDA — above typical dose 27 studies (A:0, B:11)
Vitamin C
112 mg (137% DV)
100 mg (500% DV)
Exceeds UL by 2.9× (UL: 35 mg) 196 studies (A:5, B:63)
200 mcg (286% DV)
3.6× RDA — above typical dose (UL: 0.4 mg) 173 studies (A:0, B:67)
Market median: 200.0mg (198 products) 6 studies — no high-quality reviews
250 mg
Market median: 500.0mg (283 products) 174 studies (A:0, B:62)
Market median: 100.0mg (284 products) 10 studies (A:0, B:4)

Other Ingredients

Gelatin Silicon Dioxide Magnesium Stearate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use As a dietary supplement, 1 or 2 capsules two times daily, or as directed by a healthcare practitioner.

Warnings & Precautions

Caution: Not intended for use by pregnant or lactating women.

Diabetics, use only under a physician's supervision. Seek the advice of a health professional before using this product.

Keep out of reach of children.

Do not exceed 400 micrograms of selenium per day from all sources.

Additional Information

IVC-Max provides nutrients that are involved with the utilization of Vitamin C.

Rev. 004

Keep in a cool, dry place, tightly capped.

Metadata

Product Details

UPC / SKU7 13947 74160 7
DSLD Entry Date2015-12-23
Product TypeOther Combinations
FormCapsule
BrandAllergy Research Group
DSLD ID54113
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

Vitamin D Synergy with Vitamin K1
Designs for Health · Capsule
100
Vitamin D Synergy with Vitamin K1
Designs for Health · Capsule
100
Natural Vitamin K2 45 mcg
Doctor's Best · Capsule
100
K 100 mcg
Thompson · Capsule
100
Vitamin K2 300 mcg MK-7
Innerzyme · Capsule
100
View all Vitamin K products →
Vitamin K research Best Vitamin K All Vitamin K products More from Allergy Research Group View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.